hv, Briefly - VitroGro is an adjunct therapy and the trials undertaken were designed to see whether it could kick-start the healing process with long term sufferers of ulceration where the healing process had clearly ceased functioning.
In 92% of the 58 members of the trial this end point was achieved. That is a success.
The rest is history and I am more confused than most of the way forward.
Above is all based on my memory - I cannot face another round of detailed examination of the facts, events etc that have converted this success into a 3.6cent sp.
TIS Price at posting:
3.6¢ Sentiment: Hold Disclosure: Held
